Cleared Traditional

K000121 - IMMAGE IMMUNOCHEMISTRY SYSTEM LIPOPROTEIN(A) LPAX REAGENT, ARRAY SYSTEM LIPOPROTEIN(A) LPA REAGENT, LIPOPROTEIN(A) CALIB (FDA 510(k) Clearance)

May 2000
Decision
120d
Days
Class 2
Risk

K000121 is an FDA 510(k) clearance for the IMMAGE IMMUNOCHEMISTRY SYSTEM LIPOPROTEIN(A) LPAX REAGENT, ARRAY SYSTEM LIPOPROTEIN(A) LPA REAGENT, LIPOPROTEIN(A) CALIB. This device is classified as a Lipoprotein, Low-density, Antigen, Antiserum, Control (Class II - Special Controls, product code DFC).

Submitted by Beckman Coulter, Inc. (Brea, US). The FDA issued a Cleared decision on May 17, 2000, 120 days after receiving the submission on January 18, 2000.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 866.5600.

Submission Details

510(k) Number K000121 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 18, 2000
Decision Date May 17, 2000
Days to Decision 120 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code DFC — Lipoprotein, Low-density, Antigen, Antiserum, Control
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5600